🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

225 results for “Shanghai” Clear

  1. 1% Clascoterone Cream

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  2. 5% minoxidil foam

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Androgenetic Alopecia

    phase 3 small molecule active

    1 trial

  3. 601 1.25mg

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Branch Retinal Vein Occlusion

    phase 3 small molecule completed

    2 trials

  4. 608

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Axial Spondyloarthritis, Non-Radiographic

    phase 3 small molecule active

    1 trial

  5. 608 Q2W

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Psoriasis

    phase 3 small molecule completed

    1 trial

  6. 608 Q2W

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Plaque Psoriasis Patients

    phase 3 small molecule active

    1 trial

  7. 608 dose

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Ankylosing Spondylitis

    phase 3 small molecule active

    1 trial

  8. 610

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Asthma

    phase 3 small molecule active

    2 trials

  9. 611

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Dermatitis, Atopic

    phase 3 small molecule active

    3 trials

  10. 611

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Pulmonary Disease, Chronic Obstructive (COPD)

    phase 3 small molecule active

    1 trial

  11. 611

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Sinusitis

    phase 3 small molecule active

    2 trials

  12. Azvudine

    Shanghai Henlius Biotech

    SARS-CoV-2 Infection

    phase 3 small molecule active

    1 trial

  13. Clascoterone

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  14. Clifutinib

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Leukemia, Acute Myeloid (AML)

    phase 3 small molecule active

    1 trial

  15. EPREX®

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Anemia

    phase 3 small molecule completed

    1 trial

  16. Etanercept

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

  17. FMX101

    Cutia Therapeutics (Shanghai) Co., Ltd

    Acne Vulgaris

    phase 3 small molecule completed

    1 trial

  18. GC1107

    Green Valley (Shanghai) Pharmaceuticals Co.,

    Bacterial Infections

    phase 3 mab completed

    1 trial

  19. GV-971

    Shanghai University of Traditional Chinese Medicine

    Alzheimer Disease

    phase 3 small molecule on hold

    1 trial

  20. HEC585

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 3 small molecule active

    1 trial

  21. HEC74647PA+HEC110114

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic HCV Infection

    phase 3 small molecule completed

    1 trial

  22. HLX02

    Shanghai Henlius Biotech

    Breast Cancer

    phase 3 mab completed

    1 trial

  23. Human Erythropoiesis Injection (CHO cell)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Kidney Failure, Chronic

    phase 3 small molecule active

    1 trial

  24. Hyalobarrier

    Green Valley (Shanghai) Pharmaceuticals Co.,

    Thyroid Disease

    phase 3 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources